Eupatolide is primarily used in research settings for its anti-inflammatory and anti-cancer properties. It inhibits the production of pro-inflammatory mediators by suppressing signaling pathways such as NF-κB and MAPK, reducing cytokines like TNF-α and IL-6, making it a compound of interest for chronic inflammatory diseases, including rheumatoid arthritis and type 2 diabetes models. Studies indicate that eupatolide induces apoptosis in various cancer cell lines, including leukemia, colon, liver, and lung cancers, suggesting its role as a lead compound in oncology research. Additionally, it has been investigated for its immunomodulatory effects, contributing to potential therapies for autoimmune conditions. In herbal research, it serves as a chemical marker for quality control of medicinal plants in the Eupatorium genus, traditionally used for pain and fever relief. Due to its natural origin and bioactivity, eupatolide is a valuable scaffold for synthesizing derivatives with enhanced potency and selectivity.